• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Financial effect of clinical decisions: case study of a dialysis center.

作者信息

Balas E A, Hicks L L, Stone J V, Ponferrada L P, West D A

机构信息

School of Medicine and School of Business and Public Administration, University of Missouri, Columbia, Missouri 65211, USA.

出版信息

J Med Syst. 1995 Dec;19(6):465-74. doi: 10.1007/BF02260850.

DOI:10.1007/BF02260850
PMID:8750377
Abstract

The purpose of this study was to specify the financial effect of clinical decisions in a dialysis center. A consecutive sample of 14,343 outpatient hemodialysis treatments (OHD), 16,111 continuous ambulatory peritoneal dialysis (CAPD), and 4,513 chronic cycler-assisted peritoneal dialysis (CCPD) days of treatment was analyzed. An activity-based cost calculation method was applied to the analysis of alternative treatments (service bundles). The weekly cost of OHD was higher ($338 versus $241/$242), and the contribution margin (reimbursement minus total cost) of CAPD/CCPD was much greater ($.48 versus $148/$147 per patient week). Clinical decision-making had an influence on less than 6.8% of OHD and 45.4%/46.6% of CAPD/CCPD related expenses. In comparison to activity-based cost calculation, conventional methods overestimated the overhead expense of CAPD by 3-48%. This study documented that most cost control opportunities reside in the usual process of care and less can be influenced by a direct interference with the patient-physician contacts. Paying for 1 week of renal replacement (capitation) could simplify the process of reimbursement and cost tracking.

摘要

相似文献

1
Financial effect of clinical decisions: case study of a dialysis center.
J Med Syst. 1995 Dec;19(6):465-74. doi: 10.1007/BF02260850.
2
Impact of capitation on free-standing dialysis facilities: can you survive?按人头付费对独立透析机构的影响:你能生存下去吗?
Am J Kidney Dis. 1997 Oct;30(4):542-8. doi: 10.1016/s0272-6386(97)90314-0.
3
A comparison of inpatient and outpatient Medicare allowable charges for continuous ambulatory peritoneal and center hemodialysis patients: a single-center study.持续性非卧床腹膜透析和中心血液透析患者的住院和门诊医疗保险允许收费比较:一项单中心研究。
Am J Kidney Dis. 1986 Oct;8(4):248-52. doi: 10.1016/s0272-6386(86)80034-8.
4
Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis.自动化腹膜透析与持续不卧床腹膜透析的成本-效用比较。
Arch Med Res. 2013 Nov;44(8):655-61. doi: 10.1016/j.arcmed.2013.10.017. Epub 2013 Nov 8.
5
Cost analysis of dialysis modalities in Italy.意大利透析方式的成本分析。
Health Serv Manage Res. 2001 Feb;14(1):9-17. doi: 10.1177/095148480101400102.
6
Reducing a peritoneal dialysis program's cost by changing from a vendor-provided to a program-provided system for general medical supplies: significant savings in CCPD.通过将一般医疗用品从供应商提供的系统改为项目自行提供的系统来降低腹膜透析项目的成本:持续非卧床腹膜透析可实现显著节约。
Am J Kidney Dis. 1998 Apr;31(4):662-5. doi: 10.1053/ajkd.1998.v31.pm9531183.
7
Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.新加坡终末期肾病患者血液透析和腹膜透析的成本效益
Nephrology (Carlton). 2016 Aug;21(8):669-77. doi: 10.1111/nep.12668.
8
Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.马来西亚卫生部医院中心血液透析与持续性非卧床腹膜透析的经济学评估
Nephrology (Carlton). 2005 Feb;10(1):25-32. doi: 10.1111/j.1440-1797.2005.00360.x.
9
Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.实践模式、病例组合、医疗保险支付政策和透析设施成本。
Health Serv Res. 1999 Feb;33(6):1567-92.
10
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.医疗保健系统与终末期肾病(ESRD)治疗——一项国际综述:ESRD治疗的成本及报销/资金情况
Nephrol Dial Transplant. 1999;14 Suppl 6:31-41. doi: 10.1093/ndt/14.suppl_6.31.

本文引用的文献

1
National health expenditures, 1990.1990年国家卫生支出
Health Care Financ Rev. 1991 Fall;13(1):29-54.
2
Non-medical factors that impact on ESRD modality selection.
Kidney Int Suppl. 1993 Feb;40:S120-7.
3
Geographic variation in expenditures for physicians' services in the United States.美国医师服务支出的地域差异。
N Engl J Med. 1993 Mar 4;328(9):621-7. doi: 10.1056/NEJM199303043280906.
4
The American health care system. The End Stage Renal Disease Program.美国医疗保健系统。终末期肾病项目。
N Engl J Med. 1993 Feb 4;328(5):366-71. doi: 10.1056/NEJM199302043280528.
5
Does cost information availability reduce physician test usage? A randomized clinical trial with unexpected findings.
Med Care. 1982 Mar;20(3):286-92. doi: 10.1097/00005650-198203000-00005.
6
Reuse of haemodialysis equipment: convenience and cost effectiveness.血液透析设备的再利用:便利性与成本效益。
Br Med J (Clin Res Ed). 1982 Aug 14;285(6340):473-4. doi: 10.1136/bmj.285.6340.473.
7
Cost-effective care of end-stage renal disease: a billion dollar question.
Ann Intern Med. 1980 Feb;92(2 Pt 1):243-8. doi: 10.7326/0003-4819-92-2-243.
8
Cost efficiency: a new dimension of emphasis for family practice.
J Fam Pract. 1984 Nov;19(5):601-3.
9
Comparative cost/benefit analysis in early and late dialysis.
Nephron. 1983;33(1):1-4. doi: 10.1159/000182893.
10
The costs of domiciliary maintenance haemodialysis. A comparison with alternative renal replacement regimens.
Med J Aust. 1973 Jan 27;1(4):156-9.